Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Prostatic Neoplasms 18Neoplasms 9Colonic Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Breast Neoplasms 6Uterine Cervical Neoplasms 4Colorectal Neoplasms 4Uterine Cervical Dysplasia 3Urinary Bladder Neoplasms 3Mouth Neoplasms 3Esophageal Neoplasms 3Carcinoma, Hepatocellular 3Thyroid Nodule 2Thyroid Neoplasms 2Thrombocythemia, Essential 2Testicular Neoplasms 2Rectal Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Polycythemia Vera 2Oropharyngeal Neoplasms 2Melanoma 2Lung Neoplasms 2Liver Neoplasms 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia 2Hodgkin Disease 2Glioma 2Gallbladder Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Basal Cell 2

Interventions

Sorafenib 131lenvatinib 115Bevacizumab 88Radiosurgery 69atezolizumab 55sintilimab 54Nivolumab 51durvalumab 43Hepatectomy 43Fluorouracil 42apatinib 41Oxaliplatin 41camrelizumab 38Radiofrequency Ablation 38pembrolizumab 36Radiotherapy 36tislelizumab 35Leucovorin 31Magnetic Resonance Spectroscopy 30Immune Checkpoint Inhibitors 28Doxorubicin 28Folfox protocol 26tremelimumab 25regorafenib 25Cisplatin 20spartalizumab 19donafenib 19Gemcitabine 19Cyclophosphamide 19toripalimab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Hepatocellular × Watchful Waiting × Clear all
NCT05221398 2024-09-25

Adjuvant Immune Checkpoint Inhibitors in Postoperative Hepatocellular Carcinoma

Guangxi Medical University

Completed
517 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT06089369 2024-04-30

Postoperative Adjuvant Sintilimab in Hepatocellular Carcinoma With Microvascular Invasion

Tongji Hospital

Phase 3 Not yet recruiting
360 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT01313377 2017-01-25

Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery

UNICANCER

Phase 3 Completed
190 enrolled
Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡